Muticenter, ranfdomized and controllrd clinicl study for Haoqin Huaban Prescription in the treatment of polymorphous light eruptio

Phase 1

• Conditions: Polymorphous Light Eruption

• Registration Number: ITMCTR1900002689
• Lead Sponsor: Beijing Hospital of Traditional Chinese Medcine of Captial Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. It conforms to the diagnostic standard of polymorphous light eruption in western medicine.
2. It conforms to the diagnostic standard of solar dermatitis in traditional chinese medcine.
3. Aged between 18 to 65 years;
4. Severity of illness:5cm2<the rash area<50cm2.

Exclusion Criteria

1. Other inflammatory skin diseases at exposed sites:hair dye dermatitis,contact dermatitis,etc.
2. Suffer from the systemic disease such as lupus erythematosus and dermatomyositis,which increase photosensitivity.
3. Combine the serious primary disorders like heart and cerebral vessels disease,liver and kindey disease,internal secretion disease, hemtopoiesis systematic disease,etc.Or mental disease will influence the experiment.
4. Pregnancy or nursing woman.
5. Patient who suspicious or known allergy to the ingredient of the experiment herbs.
6. Other systemic disease accompanied with dyspnea,chest distress,palpitation,anhelation,nausea,emesis and swirl,ect.
7. In process of other clincial medicine experiment.
8. Trier who is inappropriate this reaserch.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eczema Area and Severity Index;liver function;Main Clinical Syndrome Scoring Index of TCM;Skin barrier measurement;blood routine examination;routine urine test;renal function;